Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth V Goessinger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|March 17, 2025
Prurigo nodularis imitators unmaskedElisabeth V Goessinger, Tobias Kliesener, Beda Muehleisen, et al.
American Journal of Clinical Dermatology|September 11, 2024
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?Elisabeth V Goessinger, Philippe Gottfrois, Alina M Mueller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
Acta Dermato-Venereologica|November 27, 2024
Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT)Julia-Tatjana Maul, Melike Ak, Sara E Cerminara, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|March 17, 2025
Prurigo nodularis imitators unmaskedElisabeth V Goessinger, Tobias Kliesener, Beda Muehleisen, et al.
American Journal of Clinical Dermatology|September 11, 2024
Image-Based Artificial Intelligence in Psoriasis Assessment: The Beginning of a New Diagnostic Era?Elisabeth V Goessinger, Philippe Gottfrois, Alina M Mueller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
Acta Dermato-Venereologica|November 27, 2024
Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT)Julia-Tatjana Maul, Melike Ak, Sara E Cerminara, et al.
Pageof 1